Pegylated liposomal doxorubicin in the treatment of cutaneous T-cell lymphoma

J Am Acad Dermatol. 2001 Jan;44(1):149-50. doi: 10.1067/mjd.2001.109857.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / administration & dosage*
  • Doxorubicin / administration & dosage*
  • Humans
  • Liposomes
  • Lymphoma, T-Cell, Cutaneous / drug therapy*
  • Male
  • Middle Aged
  • Mycosis Fungoides / drug therapy
  • Skin Neoplasms / drug therapy*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Liposomes
  • Doxorubicin